{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:35:53Z","timestamp":1777617353368,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s11096-017-0479-6","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T08:19:42Z","timestamp":1495095582000},"page":"831-835","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of the effect of torsemide on warfarin dosage requirements"],"prefix":"10.1007","volume":"39","author":[{"given":"Sophia","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremiah D.","family":"Momper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix K.","family":"Yam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,18]]},"reference":[{"key":"479_CR1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.hfc.2009.11.001","volume":"6","author":"SA Lubitz","year":"2010","unstructured":"Lubitz SA, Benjamin EJ, Ellinor PT. Atrial fibrillation in congestive heart failure. Heart Fail Clin. 2010;6:187\u2013200.","journal-title":"Heart Fail Clin"},{"key":"479_CR2","doi-asserted-by":"crossref","first-page":"2D","DOI":"10.1016\/S0002-9149(02)03373-8","volume":"91","author":"WH Maisel","year":"2003","unstructured":"Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91:2D\u20138D.","journal-title":"Am J Cardiol"},{"key":"479_CR3","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","volume":"119","author":"E Anter","year":"2009","unstructured":"Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009;119:2516\u201325.","journal-title":"Circulation"},{"key":"479_CR4","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/j.jacc.2014.03.021","volume":"64","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e20\u20132.","journal-title":"J Am Coll Cardiol"},{"key":"479_CR5","unstructured":"Product information. Coumadin (warfarin). Princeton: Bristol-Myers Squibb Company, August 2007."},{"key":"479_CR6","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0022-3565(25)24531-1","volume":"272","author":"JO Miners","year":"1995","unstructured":"Miners JO, Rees DLP, Valente L, Veronese ME, Birkett DJ. Human hepatic cytochrome P450 2C9 catalyses the rate-limiting pathway of torsemide metabolism. J Pharmacol Exp Ther. 1995;272:1076\u201381.","journal-title":"J Pharmacol Exp Ther"},{"key":"479_CR7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00008571-200004000-00008","volume":"10","author":"JO Miners","year":"2000","unstructured":"Miners JO, Coulter S, Birkett DJ, Goldstein JA. Torsemide metabolism by CYP2C9 variants and other human CYP2C subfamiliy enzymes. Pharmacogenetics. 2000;10:267\u201370.","journal-title":"Pharmacogenetics"},{"key":"479_CR8","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1345\/aph.1L306","volume":"42","author":"J Bird","year":"2008","unstructured":"Bird J, Carmona C. Probable interaction between warfarin and torsemide. Ann Pharmacother. 2008;42:1893\u20138.","journal-title":"Ann Pharmacother"},{"key":"479_CR9","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/jphp.12084","volume":"65","author":"HO Kim","year":"2013","unstructured":"Kim HO, Lee KE, Park HY, Lee NR, Oh BR, Chang BC, et al. Effects of torsemide on pharmacodynamics and pharmacokinetics of warfarin in humans and rats. J Pharm Pharmacol. 2013;65:1195\u2013203.","journal-title":"J Pharm Pharmacol"},{"key":"479_CR10","unstructured":"Product information. Demadex (torsemide). Nutley: Roche Pharmaceuticals, April 2003."},{"key":"479_CR11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1345\/aph.1H423","volume":"41","author":"JR Horn","year":"2007","unstructured":"Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41:674\u201380.","journal-title":"Ann Pharmacother"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-017-0479-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-017-0479-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-017-0479-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T17:50:40Z","timestamp":1750269040000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-017-0479-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1007\/s11096-017-0479-6","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,18]]}}}